Objective: To investigate the clinical application value of Danhong injection combined with edaravone in treatment of acute cerebral infarction. Method: One hundred and twenty-six cases patients with acute cerebral infarction were selected

63 of them in control group and experimental group each. Both group received general rehabilitation measures such as daily oxygen uptake

anticoagulation treatment

brain cells protection. Additionally

control group got edaravone intravenously only and experimental group received Danhong injection combined with edaravone. 10 days was taken as a course. After three courses

degree of neurological impairment and improvement of daily living activities was evaluated and compared with before. Result: The NIHSS score of neurological deficit was significant lower in the experimental group than the control group

and the activities of daily living(ADL) score of daily living ability was significant higher in the experimental group than the control group. Both the difference were statistically significant. Overall efficiency of the experimental group was 91.67%

significantly better than the control group's 70.21%. Conclusion: It is a safe and effective method to use Danhong injection combined with edaravone in treatment of acute cerebral infarction. The combination therapy is better than edaravone monotherapy and it's worthy of promotion in clinical practice.